World News: 16:11 GMT Monday 5th February 2018. [Capricor Therapeutics, Inc. via Globe Newswire via SPi World News]
LOS ANGELES Feb 05 2018 GLOBE NEWSWIRE -- NASDAQCAPR today announced that the US Food and Drug Administration FDA has granted CAP-1002 its lead investigational cell therapy for the treatment of Duchenne muscular dystrophy the Regene rative ...
Globe Newswire: 16:11 GMT Monday 5th February 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.